Finalists announced for NIH's RADx® Tech Fetal Monitoring Challenge - CIMIT MAIN
We are thrilled to announce that we’ve been selected as one of the first spokes of the ARPA-H Investor Catalyst Hub network!
We are excited to be a part of this nationwide network dedicated to accelerating groundbreaking advances in science and medicine—all in pursuit of better health outcomes for everyone.
Learn more >
Programs and Offerings
NIH awards interim prizes in fetal diagnostic and monitoring technology competition
The National Institutes of Health has announced the finalists in its competition to accelerate the development of diagnostic and monitoring technologies to improve fetal health outcomes focusing on low-resource settings.
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Bill & Melinda Gates Foundation partnered to launch the RADx® Tech Fetal Monitoring Challenge in September 2023. The multi-phased competition aims to address the causes of fetal morbidity and mortality, including the estimated 2 million incidences of stillbirth that occur globally each year, with over 24,000 that occur in the United States alone. Novel and accessible technologies are needed to enable earlier and more accurate diagnosis, detection, and monitoring of fetal health status.
News and Events
A new RADx® Tech fellowship helps underrepresented innovators advance their technology
C-THAN Receives up to $8 Million in Funding over Five Years
St. John’s Research Institute part of global collaborative effort to develop point-of-care diagnostic technologies
UMass Chan and UMass Lowell’s point-of-care technology initiative awarded $8.9 million renewal
Connect with Us
Our Lasting Impact
We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.